Home/News/Ipamorelin vs CJC-1295

Peptide Comparison

GH Peptides

Ipamorelin vs CJC-1295: What's the Difference?

Ipamorelin and CJC-1295 are two of the most widely researched growth hormone-related peptides — and among the most commonly stacked compounds in peptide protocols. Yet they work through completely different mechanisms. Understanding the difference is essential for using them correctly, alone or together.

Ipamorelin

GHRP — Ghrelin Receptor Agonist

• Short half-life (~2 hours)

• Triggers a sharp, clean GH pulse

• Minimal cortisol/prolactin elevation

• Works at the pituitary via ghrelin receptor

• Dosed 2–3x daily

CJC-1295

GHRH Analog — GHRH Receptor Agonist

• No DAC: ~30 min half-life | DAC: ~8 days

• Amplifies and sustains GH release signal

• No cortisol or prolactin elevation

• Works at the hypothalamic/pituitary axis

• No DAC: 2–3x daily | DAC: weekly

How Each Peptide Works

Ipamorelin — The GH Pulse Trigger

Ipamorelin is a growth hormone releasing peptide (GHRP) — specifically a selective ghrelin receptor agonist (GHS-R1a). When administered, it binds to ghrelin receptors in the pituitary and hypothalamus, triggering the direct release of growth hormone in a sharp, pulsatile manner. What makes Ipamorelin stand out among GHRPs is its selectivity: it produces GH release with very little elevation of cortisol or prolactin — a common side effect of other GHRPs like GHRP-6 or Hexarelin. This "clean" pulse profile makes it one of the safest and most beginner-friendly GH-stimulating peptides available.

CJC-1295 — The GH Signal Amplifier

CJC-1295 is a growth hormone releasing hormone (GHRH) analog — a modified version of the endogenous GHRH peptide that your hypothalamus naturally produces. It binds to GHRH receptors in the anterior pituitary, stimulating GH synthesis and release. CJC-1295 comes in two forms: with DAC (Drug Affinity Complex), which extends half-life to approximately 8 days for weekly dosing, and without DAC, which has a short ~30-minute half-life and is designed for pulsatile use. CJC-1295 does not trigger a GH pulse on its own as dramatically as a GHRP — it amplifies and sustains the GH release signal, making it most effective when combined with a GHRP like Ipamorelin.

Side-by-Side Comparison

	Ipamorelin	CJC-1295
Class	GHRP (Growth Hormone Releasing Peptide)	GHRH (Growth Hormone Releasing Hormone)
Mechanism	Binds ghrelin receptor; triggers GH pulse from pituitary	Mimics endogenous GHRH; amplifies GH release signal
Half-life	~2 hours	No DAC: ~30 min \| With DAC: ~8 days
Typical Dose	100–300 mcg per injection	No DAC: 100–200 mcg \| With DAC: 1–2 mg/week
Injection Frequency	2–3x daily	No DAC: 2–3x daily \| With DAC: Once weekly
GH Pulse Type	Initiates a sharp, clean GH pulse	Amplifies and sustains the GH pulse
Cortisol/Prolactin effect	Minimal — selective for GH	Minimal
Hunger stimulation	Mild — less than GHRP-6	None
Best for	Selective GH stimulation, sleep quality, body composition	Sustained GHRH signal, stacking with GHRPs

CJC-1295: With DAC vs Without DAC

This is one of the most common points of confusion in peptide research. The two forms of CJC-1295 behave very differently:

CJC-1295 Without DAC

(also called Mod GRF 1-29)

• Half-life: ~30 minutes

• Dosed 2–3x daily alongside Ipamorelin

• Produces a natural pulsatile GH pattern

• Preferred for stacking — matches Ipamorelin's timing

• More physiologically mimetic

CJC-1295 With DAC

(longer-acting version)

• Half-life: ~8 days

• Dosed once weekly (1–2 mg)

• Produces a sustained "GH bleed" effect

• Less pulsatile — some researchers prefer no-DAC

• Can be stacked separately from daily Ipamorelin

Why Are They Always Stacked Together?

Ipamorelin and CJC-1295 are the most popular peptide stack in GH-related research — and for good reason. They activate two completely different receptor systems that normally work together in the body to regulate GH release:

Ipamorelin triggers a GH pulse from the pituitary (via ghrelin receptor).

CJC-1295 amplifies that pulse by simultaneously stimulating the GHRH receptor — a different pathway.

Together they produce a significantly larger GH release than either compound alone.

The synergy mimics the natural two-signal system (GHRH + ghrelin) that governs GH secretion in healthy physiology.

No DAC CJC-1295 is preferred for this stack — it matches Ipamorelin's short-acting pulse pattern.

Stack Protocol Examples

Standard Stack

Ipamorelin Dose

100–200 mcg

CJC-1295 Dose

100–200 mcg (no DAC)

Timing

Before bed (fasted), 2–3x daily

Cycle

8–12 weeks on, 4 weeks off

GH Optimization

Ipamorelin Dose

200–300 mcg

CJC-1295 Dose

200 mcg (no DAC) or 1–2 mg DAC weekly

Timing

Morning (fasted) + pre-sleep

Cycle

12 weeks on, 4–6 weeks off

Which Should You Research First?

Start with Ipamorelin if…

✓ You want a beginner-friendly GHRP
✓ You want selective GH release with minimal side effects
✓ You're new to GH peptide protocols
✓ You want to assess GH response before adding a GHRH

Add CJC-1295 when…

✓ You've established Ipamorelin tolerance
✓ You want to amplify GH output from the same injection
✓ You're ready for a synergistic GH-optimizing stack
✓ You want once-weekly dosing convenience (DAC version)

Calculate Your Dose

Use the Peptide Basics calculator to find the exact draw volume for your Ipamorelin and CJC-1295 vials based on your BAC water and vial size.

Open the Calculator

→ Tesamorelin vs Ipamorelin: What's the Difference?→ Peptide Dosing Guide: Beginner to Advanced → Best Peptides for Muscle Growth → Ipamorelin Research Profile

Disclaimer: This article is for educational and research purposes only. Not medical advice. Consult a licensed healthcare provider before using any peptide compound.

← Back to News